These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 23953551)

  • 41. Simultaneous heart and kidney transplantation from a single donor.
    Hsu RB; Tsai MK; Lee PH; Lee CM; Chen MF; Wang SS; Lin FY; Chu SH
    Eur J Cardiothorac Surg; 2008 Dec; 34(6):1179-84. PubMed ID: 18835781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of acute renal dysfunction after ventricular assist device placement.
    Alba AC; Rao V; Ivanov J; Ross HJ; Delgado DH
    J Card Fail; 2009 Dec; 15(10):874-81. PubMed ID: 19944364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation.
    Reinhartz O; Farrar DJ; Hershon JH; Avery GJ; Haeusslein EA; Hill JD
    J Thorac Cardiovasc Surg; 1998 Oct; 116(4):633-40. PubMed ID: 9766593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal failure in patients with left ventricular assist devices.
    Patel AM; Adeseun GA; Ahmed I; Mitter N; Rame JE; Rudnick MR
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):484-96. PubMed ID: 23065497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bridge to Transplantation With Long-Term Mechanical Assist Devices in Adults With Transposition of the Great Arteries.
    Michel E; Orozco Hernandez E; Enter D; Monge M; Nakano J; Rich J; Anderson A; Backer C; McCarthy P; Pham D
    Artif Organs; 2019 Jan; 43(1):90-96. PubMed ID: 30129258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationship between bridging with ventricular assist device on rejection after heart transplantation.
    Pamboukian SV; Costanzo MR; Dunlap S; Rayburn B; Westfall AO; You ZY; Hung E; McLeod M; Heroux A
    J Heart Lung Transplant; 2005 Mar; 24(3):310-5. PubMed ID: 15737758
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantation.
    Petroni T; D'Alessandro C; Combes A; Golmard JL; Brechot N; Barreda E; Laali M; Farahmand P; Varnous S; Weber P; Pavie A; Leprince P
    Arch Cardiovasc Dis; 2019; 112(8-9):485-493. PubMed ID: 31353279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
    Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Extracorporeal membrane oxygenation and Thoratec pneumatic ventricular assist devices as double bridge to heart transplantation.
    Chou NK; Luo JM; Chi NH; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Chu SH; Wang SS
    Transplant Proc; 2012 May; 44(4):878-80. PubMed ID: 22564572
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuous-flow ventricular assist device exchange is safe and effective in prolonging support time in patients with end-stage heart failure.
    Anand J; Singh SK; Hernández R; Parnis SM; Civitello AB; Cohn WE; Mallidi HR
    J Thorac Cardiovasc Surg; 2015 Jan; 149(1):267-75, 278.e1. PubMed ID: 25312232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.
    Alba AC; Tinckam K; Foroutan F; Nelson LM; Gustafsson F; Sander K; Bruunsgaard H; Chih S; Hayes H; Rao V; Delgado D; Ross HJ
    J Heart Lung Transplant; 2015 May; 34(5):685-92. PubMed ID: 25638296
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Body mass index and outcome after ventricular assist device placement.
    Musci M; Loforte A; Potapov EV; Krabatsch T; Weng Y; Pasic M; Hetzer R
    Ann Thorac Surg; 2008 Oct; 86(4):1236-42. PubMed ID: 18805168
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model.
    Pamboukian SV; Tallaj JA; Brown RN; Nielsen T; George JF; Kirklin JK; Holman WL; Levy WC
    ASAIO J; 2012; 58(2):93-7. PubMed ID: 22370679
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device.
    Russell SD; Rogers JG; Milano CA; Dyke DB; Pagani FD; Aranda JM; Klodell CT; Boyle AJ; John R; Chen L; Massey HT; Farrar DJ; Conte JV;
    Circulation; 2009 Dec; 120(23):2352-7. PubMed ID: 19933938
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antithymocyte globulin induction therapy adjusted for immunologic risk after heart transplantation.
    Czer LS; Phan A; Ruzza A; Rafiei M; Setareh-Shenas S; Caceres M; Awad M; Soliman C; Mirocha J; De Robertis M; Kass RM; Trento A
    Transplant Proc; 2013; 45(6):2393-8. PubMed ID: 23953554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantifying the effect of cardiorenal syndrome on mortality after left ventricular assist device implant.
    Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Givertz MM; Young JB
    J Heart Lung Transplant; 2013 Dec; 32(12):1205-13. PubMed ID: 24119728
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Ventricular assist device and heart transplantation in Japan].
    Ono M
    Masui; 2009 Mar; 58(3):327-36. PubMed ID: 19306633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.